Urofollitropin
Applications, Mechanism, and Importance in Assisted Reproductive Technology
Urofollitropin, also known as recombinant follicle-stimulating hormone (rFSH), is a key medicine in assisted reproductive technology (ART). It stimulates ovarian follicle growth and maturation, which is critical for successful fertilization and pregnancy.
What is Urofollitropin, and Why is it Important?
Used in fertility treatments like IVF and ICSI, urofollitropin externally stimulates the ovary, mimicking natural follicle development. Multiple follicles-and thus multiple eggs-can mature simultaneously, increasing the likelihood of successful fertilization and healthy embryo development.
How does Urofollitropin work?
Urofollitropin binds to follicle-stimulating hormone receptors (FSHRs) on granulosa cells in the ovarian follicle, triggering signals that support:
- Follicle recruitment
- Follicle growth
- Oocyte maturation
This enhances the chances of retrieving multiple mature, high-quality eggs during an IVF cycle.
Personalized Dosing for Optimal Results
Dosages can be tailored to individual patients based on:
- Ovarian reserve
- Hormonal profile
- Past reproductive results
- Ultrasound and blood test findings
This personalized approach maximizes success while reducing risks such as ovarian hyperstimulation syndrome (OHSS).
Uses Beyond IVF
Although primarily used in IVF and ICSI, urofollitropin is effective in other fertility treatments:
- Intrauterine insemination (IUI): stimulates ovaries for better natural fertilization chances.
- Treatment of ovarian dysfunction (eg, PCOS)
- Unexplained infertility: encouraging consistent ovulation to improve outcomes
Conclusion
Urofollitropin remains a powerful and reliable option in modern reproductive medicine. By promoting healthy follicle development and improving egg quality and quantity, it gives hope to individuals and couples struggling with infertility, representing a vital step toward achieving parenthood.